US STOCK
TVTX Stock Analysis
US stocks · market data · technical indicators
Travere Therapeutics, Inc.
TVTXUS stocksQuote delayed 15 min
10/26 上午10:33 updated
$50.08
-2.35-4.48%
Open
$52.00
High
$52.22
Low
$49.78
Volume
231.46萬
TVTX price history
-18.66%Open
61.57
Latest
50.08
High
61.57
Low
49.60
Average
54.14
Advertisement
Financial snapshot
TVTX - Travere Therapeutics, Inc.
EPS
-0.74USD
Forward EPS
5.70USD
P/E
--
Forward P/E
8.78x
P/B
192.62x
ROE
-236.36%
ROA
-3.73%
Operating margin
2.33%
Profit margin
-7.35%
Revenue growth
48.20%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $169.58M | $127.20M | $129.69M | $164.86M | $114.45M |
| Gross profit | $160.35M | $100.43M | $127.14M | $163.27M | $99.29M |
| Operating income | $3.95M | -$36.91M | -$32.43M | $24.93M | -$12.65M |
| Net income | -$34.80M | -$37.10M | $2.73M | $25.71M | -$12.76M |
| Basic EPS | -0.37 | -0.40 | 0.03 | 0.29 | -0.14 |
| Diluted EPS | -0.37 | -0.40 | 0.03 | 0.28 | -0.14 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
0.49
Revenue estimate
$198.32M
Last surprise
-131.02%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | 0.49 | Not reported | — |
| 2026-08-04 | 0.32 | -0.10 | -131.02% |
| 2026-05-04 | -0.06 | 0.05 | +187.00% |
| 2026-02-19 | 0.37 | 0.37 | -0.77% |
| 2025-10-30 | -0.08 | 0.59 | +794.12% |
| 2025-08-06 | 0.04 | 0.13 | +225.00% |
| 2025-05-01 | -0.39 | -0.19 | +51.81% |
| 2025-02-20 | -0.38 | -0.47 | -24.15% |
| 2024-10-31 | -0.54 | -0.46 | +14.26% |
| 2024-08-01 | -0.72 | -0.65 | +9.24% |
| 2024-05-06 | -0.79 | -1.51 | -90.61% |
| 2024-02-15 | -0.92 | -0.94 | -2.05% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| STATE STREET CORP | 2026-06-30 | $241.8M | 0.01% |
| VANGUARD GROUP INC | 2025-12-31 | $241.1M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $104.1M | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $88.9M | 0.06% |
| BlackRock Inc. | 2024-06-30 | $62.8M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $2.2M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$75.21
Target range
$62.00 – $90.00
Implied upside
50.19%
Strong buy
2
Buy
12
Hold
1
Sell
0
Strong sell
0
Advertisement